Trials / Withdrawn
WithdrawnNCT02393183
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease, a Placebo Controlled Randomized Clinical Trial
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Iran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This randomized clinical trial is designed to evaluate the effect of selected antioxidant vitamins and minerals supplement named as ASTED: 1. β- Carotene (30 mg) 2. Vit C (100 mg) 3. Vit E (Alpha-Tocopherol Acetate): 60-200 IU 4. Calcium phosphate dihydrate (40 mg) 5. Zinc oxide (4 mg, elemental) 6. Copper gluconate (3.5 mg) 7. Sodium selenite 23 mg= Selenium 100 µg 8. Nicotinamide (a form of vit.B3) (10 mg) in patients with mild Thyroid eye disease according to EUGOGO classification. To be given twice a day.
Detailed description
1. To determine total eye score (NOSPECS severity score) before and after treatment in each of the three arms of the study and make a before - after as well as an inter-arm comparison. 2. To determine Score of thyroid eye disease Quality of life questionnaire (TED-QOL) before and after treatment in each of the three arms of the study and make a before - after as well as an inter-arm comparison. 3. To determine clinical activity score (CAS Score) before and after treatment in each of the three arms of the study and make a before - after as well as an inter-arm comparison. 4. To determine Serum thyroid auto-antibodies (Anti thyroid peroxidase (TPO), Anti-thyrogluboline) and Thyroid function test (Free T4, T3, and TSH) level before and after treatment in each of the three arms of the study and make a before - after as well as an inter-arm comparison. 5. To determine the rate of side effects in each arm and make a comparison.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASTED | A tablet of ASTED will be taken twice a day |
| DIETARY_SUPPLEMENT | Selenium | A tablet of 100 microgram of Selenium (same shape and color) will be taken twice a day |
| OTHER | Placebo | A tablet of Placebo (same shape and color) will be taken twice a day |
Timeline
- Start date
- 2019-07-15
- Primary completion
- 2022-06-15
- Completion
- 2022-12-15
- First posted
- 2015-03-19
- Last updated
- 2023-09-28
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02393183. Inclusion in this directory is not an endorsement.